Because atrial fibrillation is a major risk factor for ischemic stroke, there is a need for strategies to identify people at risk for stroke and prevent it at all ages. The American Academy of Neurology (AAN) has helped fill this gap with the release of new evidence-based guidelines.
Patients with stroke often require extensive inpatient and outpatient care that is associated with high expenditures and very high morbidity and mortality rates. Neuroimaging is an important component of care in patients with acute ischemic stroke, especially for guiding the use of thrombolysis. Imaging is associated with high costs and is being used more often today.
Glatiramer Acetate Injection Cost-Effective for Relapse Prevention in Patients with Multiple Sclerosis
A recent Spanish economic analysis indicates that glatiramer acetate injection (Copaxone) is cost-effective for the prevention of relapses in patients with established relapsing-remitting multiple sclerosis (RRMS), according to recently published results.
Blinding of patients to their assigned treatment (active or placebo) is a standard procedure in clinical trials to assess the “true” efficacy of the active drug. But what happens when patients are certain whether they are receiving active treatment or placebo?
Growing Understanding of Genetic Causes of Progressive Myoclonic Epilepsies Improves the Diagnostic Workup
The varied genetic causes of progressive myoclonic epilepsies (PMEs) are becoming better understood through genetic analyses. A team of Italian researchers recently contributed to the understanding of these rare diseases by defining the clinical spectrum and etiology of PMEs, using a database developed by the Genetics Commission of the Italian League against Epilepsy.
Men with N-methyl-D-aspartate (NMDA) receptor antibodies (NMDAr-Abs) encephalitis present different from women, according to a recent study. Adult men are more likely to present with seizures, whereas women rarely present with seizures and are much more likely to present with behavioral and psychiatric features as their first symptom. Males and females have a similar course of global progression and similar recovery.
Neurologists Propose New Algorithm for First-Line Natalizumab in Selected Patients with Multiple Sclerosis
Page 1 of 3
Results 1 - 10 of 21
Results 1 - 10 of 21